Table 1. Demographics and baseline characteristics of the sample.
| Characteristics | Values | % |
|---|---|---|
| Age, years | 41.4±11.6 | – |
| Sex, male/female | 382/1,042 | 26.8/73.2 |
| BMI | 23.1±3.9 | – |
| NG | 709 | 49.8 |
| HD | 340 | 23.9 |
| Hypertension | 117 | 8.2 |
| Diabetes | 45 | 3.2 |
| Hypothyroidism | 26 | 1.8 |
| Hyperthyroidism | 34 | 2.4 |
| Tumor size (mm) | 14.1±8.9 | – |
| Multifocality | 347 | 24.4 |
| Capsule invasion | 586 | 41.2 |
| TNM stage | ||
| Tx/T1/T2/T3/T4 | 8/756/92/501/66 | 6.0/53.1/6.5/35.2/4.6 |
| Nx/N0/N1a/N1b | 9/573/484/356 | 0.6/40.2/34.0/25.0 |
| No. of identified PGs (3/4) | 212/1212 | 14.9/85.1 |
| Accidental resection | 94 | 6.6 |
| No. of PGs after excluding accidental resection (3/4) | 182/1,148 | 13.7/86.3 |
| Hypoparathyroidism | ||
| Transient | 766 | 53.8 |
| Permanent | 21 | 1.5 |
BMI, body mass index; HD, Hashimoto’s disease; NG, nodular goiter; TNM, tumor node metastasis; No. of identified PGs, number of identified parathyroid glands; No. of PGs, number of parathyroid glands with no accidental resection.